Clinical trial
Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer
NCT01200810
Study timeline
Study start (unknown)2010-08-01Date precision: month
Registry last updated2017-12-02
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Adenocarcinoma of the Prostateunresolved
Recurrent Prostate Cancerunresolved
Stage IV Prostate Cancerunresolved
Interventions
placeboOTHER
bicalutamideDRUG · verified · RxNorm: bicalutamide
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01200810 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.